Your Health, We Care

Home > Drug List > Orforglipron > News of Orforglipron

News of Orforglipron

On April 1, 2026, the U.S. Food and Drug Administration (FDA) approved orforglipron for launch. It is currently the only oral GLP-1 tablet indicated for weight loss that can be taken at any time of day with no food or water restrictions.

Medicine-related columns

Related Articles

There is no data under this category!